The global enoxolone market is expected to grow at a significant CAGR during the forecast period (2021-2027). One of the major bioactive components of liquorice is enoxolone (glycyrrhizic acid), a pentacyclic triterpenoid aglycone metabolite of glycyrrhizin. It's often used in medicine to treat chronic dermatitis and peptic ulcers, as well as in cosmetics. Antibacterial, antifungal, antiprotozoal, and antiviral activities are among its other pharmacological characteristics. When enoxolone is given, it prevents both prostaglandin reductase and 15-hydroxyprostaglandin dehydrogenase [NAD(+)] from metabolizing prostaglandins.

Due to changes in lifestyle and unhealthy eating habits, the number of individuals suffering from chronic diseases is rising. This, in turn, supports the global enoxolone market's growth. In the US, for instance, 4.6 million instances of peptic ulcers are reported each year. The global market is expected to grow as the prevalence of chronic dermatitis rises. Eczema is quite prevalent, especially among youngsters and those who suffer from hay fever, asthma, or food allergies. According to the National Eczema Association, over 10% of Americans, or 31.6 million people, suffer from eczema.

Furthermore, rising research funding, government initiatives to improve healthcare facilities, and a focus on research are all anticipated to drive the global enoxolone market's growth. In the global enoxolone market, the rise in incidence and awareness of chronic illnesses, as well as government efforts in developing countries, provide attractive prospects.

In both developing and developed nations, the demand for enoxolone has grown. To extend their footprint, market companies are employing third-party distributors. As a result, the number of distributors and suppliers in developing countries has increased dramatically. This opens up a significant market potential. For instance, Selleck Chemicals provides approximately 120,000 inhibitors for the research of cell signalling networks. BioVision, Inc. has a robust distribution channel in Argentina, Australia, Belgium, Brazil, Canada, China, the Czech Republic, Denmark, France, and Germany.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Type 

o By Application 

o By Distribution Channel 

• Region Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

• Competitive Landscape: Merck KGaA (Sigma-Aldrich, Inc.), Alchem International Pvt. Ltd., Biosynth Carbosynth, BioVision, Inc., and Tokiwa Phytochemical Co., Ltd. among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Enoxolone Market by Segments

By Type

• Oral
• Tropical

By Application

• Chronic Dermatitis

o Eczema

o Frostbite

• Peptic Ulcer
• Antitussive

By Distribution Channel

• Online Pharmacy
• Hospital Pharmacy
• Retail Stores

Global Enoxolone Market by Region